Maria Di Girolamo
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Toxin Mechanisms and Immunotoxins, Calcium signaling and nucleotide metabolism, Inflammatory Bowel Disease, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Energy-Efficient Cloud Computing(2009)652 cited
- → Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury(2004)336 cited
- → Combining affinity purification by ADP-ribose-binding macro domains with mass spectrometry to define the mammalian ADP-ribosyl proteome(2009)111 cited
- → Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review(2022)103 cited
- → Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease(2018)96 cited
- → Physiological relevance of the endogenous mono(ADP‐ribosyl)ation of cellular proteins(2005)94 cited
- → PARP16/ARTD15 Is a Novel Endoplasmic-Reticulum-Associated Mono-ADP-Ribosyltransferase That Interacts with, and Modifies Karyopherin-ß1(2012)85 cited
- → Stimulation of endogenous ADP-ribosylation by brefeldin A.(1994)78 cited
- → Proton pump inhibitors in cirrhosis: Tradition or evidence based practice?(2008)76 cited
- → ARTC1-mediated ADP-ribosylation of GRP78/BiP: a new player in endoplasmic-reticulum stress responses(2014)64 cited